Meta-analysis in genome-wide association studies

Pharmacogenomics

Volumn 10, Issue 2, 2009, Pages 191-201

  Zeggini, Eleftheria ^a,b   Ioannidis, John P A ^c,d,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF IOANNINA   (Greece)

^d INSTITUTE OF COMPUTER SCIENCE   (Greece)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genome wide association studies; Heterogeneity; Meta analysis methods; Replication

Indexed keywords

ANALYTIC METHOD; EFFECT SIZE; GENE LOCUS; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEALTH CARE FACILITY; HUMAN; INFORMATION PROCESSING; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACOGENETICS; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; BIOMETRY; GENETIC DATABASE; HUMAN GENOME; META ANALYSIS; METHODOLOGY; STANDARD;

BIOMETRY; DATABASES, GENETIC; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; META-ANALYSIS AS TOPIC;

EID: 65249183403     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.10.2.191     Document Type: Review

References (54)

1. Ioannidis JP: Why most published research findings are false. PLoS Med. 2, E124 (2005).
2. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K: A comprehensive review of genetic association studies. Genet. Med. 4, 45-61 (2002).
3. Burton PR, Hansell AL, Fortier I et al.: Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int. J. Epidemiol. (2008) (Epub ahead of print).
4. International HapMap Consortium: A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861 (2007).
5. McCarthy MI, Abecasis GR, Cardon LR et al.: Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9(5), 356-369 (2008).
6. Manolio TA, Brooks LD, Collins FS: A HapMap harvest of insights into the genetics of common disease. J. Clin. Invest. 118(5), 1590-1605 (2008).
7. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F: Methods for Meta-Analysis in Medical Research. John Wiley and Sons Ltd, Chichester, UK (2000).
8. Higgins JP, Little J, Ioannidis JP et al.: Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am. J. Epidemiol. 166, 863-866 (2007).
9. Anderson CA, Pettersson FH, Barrett JC et al.: Evaluating the effects of imputation on the power, coverage, and cost efficiency of genome-wide SNP platforms. Am. J. Hum. Genet. 83(1), 112-119 (2008).
10. Seminara D, Khoury MJ, O'Brien TR et al.: The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology 18, 1-8 (2007).
11. Ioannidis JP, Bernstein J, Boffetta P et al.: A network of investigator networks in human genome epidemiology. Am. J. Epidemiol. 162, 302-304 (2005).
12. Rothstein HR, Sutton AJ, Borestein M (Eds). Publication Bias in Meta-Analysis - Prevention, Assessment and Adjustments. John Wiley and Sons Ltd, Chichester, UK (2005).
13. Barrett JC, Cardon LR: Evaluating coverage of genome-wide association studies. Nat. Genet. 38(6), 659-662 (2006).
14. Mailman MD, Feolo M, Jin Y et al.: The NCBI dbGaP database of genotypes and phenotypes. Nat. Genet. 39(10), 1181-1186 (2007).
15. Manolio TA, Rodriguez LL; GAIN Collaborative Research Group et al.: New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat. Genet. 39(9), 1045-1051 (2007).
16. Hoggart CJ, Clark TG, De Iorio M, Whittaker JC, Balding DJ: Genome-wide significance for dense SNP and resequencing data. Genet. Epidemiol. 32(2), 179-185 (2008).
17. Ioannidis JP: Why most discovered true associations are inflated. Epidemiology 19(5), 640-648 (2008).
18. Little J, Higgins JPT, Ioannidis JPA et al.: Strengthening the reporting of genetic association studies. Ann. Intern. Med. (2009) (In Press).
19. Yesupriya A, Evangelou E, Kavvoura FK et al.: Reporting of human genome epidemiology (HuGE) association studies: an empirical assessment. BMC Med. Res. Methodol. 8, 31 (2008).
20. Contopoulos-Ioannidis DG, Alexiou GA, Gouvias TC, Ioannidis JP: An empirical evaluation of multifarious outcomes in pharmacogenetics: β-2 adrenoceptor gene polymorphisms in asthma treatment. Pharmacogenet. Genomics 16, 705-711 (2006).
21. Cardon LR, Palmer LJ: Population stratification and spurious allelic association. Lancet 361, 598-604 (2003).
22. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D: Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
23. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P: Association mapping in structured populations. Am. J. Hum. Genet. 67, 170-181 (2000).
24. Kavvoura FK, Ioannidis JP: Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum. Genet. 123(1), 1-14 (2008).
25. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558 (2002).
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 327, 557-560 (2003).
27. Ioannidis JP, Patsopoulos NA, Evangelou E: Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335, 914-916 (2007).
28. Moonesinghe R, Khoury MJ, Liu T, Ioannidis JP: Required sample size and nonrepticability thresholds for heterogeneous genetic associations. Proc. Natl Acad. Sci. USA 105(2), 617-622 (2008).
29. Ioannidis JP: Non-replication and inconsistency in the genome-wide association setting. Hum. Hered. 64, 203-213 (2007).
30. Evangelou E, Maraganore DM, Ioannidis JP: Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease. PLoS ONE 2, E196 (2007).
31. Ioannidis JP, Patsopoulos NA, Evangelou E: Heterogeneity in meta-analyses of genome-wide association investigations. PLoS ONE 2, E841 (2007).
32. Hunter DJ, Khoury MJ, Drazen JM: Letting the genome out of the bottle - will we get our wish? N. Engl. J. Med. 358(2), 105-107 (2008).
33. Zollner S, Pritchard JK: Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am. J. Hum. Genet. 80(4), 605-615 (2007).
34. Lau J, Schmid CH, Chalmers TC: Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J. Clin. Epidemiol. 48, 45-57 (discussion 59-60) (1995).
35. Spiegelhalter DJ, Thomas A, Best NG, Lunn D: WinBUGS Version 1.4 Users Manual MRC Biostatistics Unit, Cambridge, UK (2003).
36. Spiegelhalter DJ, Abrams KR, Myles PJ: Evidence Synthesis. John Wiley and Sons Ltd, Chichester, UK (2004).
37. Salanti G, Higgins JP, Trikalinos TA, Ioannidis JP: Bayesian meta-analysis and meta-regression for gene-disease associations and deviations from Hardy-Weinberg equilibrium. Stat. Med. 26, 553-567 (2007).
38. Thorlund K, Devereaux PJ, Wetterslev J et al.: Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int. J. Epidemiol. (In Press).
39. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N: Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst. 96, 434-442 (2004).
40. Wakefield J: A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am. J. Hum. Genet. 81, 208-227 (2007).
41. Ioannidis JP: Calibration of credibility of agnostic genome-wide associations. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B(6), 964-972 (2008).
42. Zeggini E, Scott LJ, Saxena R et al.: Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for Type 2 diabetes. Nat. Genet. 40(5), 638-645 (2008).
43. Saxena R, Voight BF, Lyssenko V et al.: Genome-wide association analysis identifies loci for Type 2 diabetes and triglyceride levels. Science 316, 1331-1336 (2007).
44. Scott LJ, Mohlke KL, Bonnycastle LL et al.: A genome-wide association study of Type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345 (2007).
45. Zeggini E, Weedon MN, Lindgren CM et al.: Replication of genome-wide association signals in U.K. samples reveals risk loci for Type 2 diabetes. Science 316, 1336-1341 (2007).
46. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
47. Frayling TM, Timpson NJ, Weedon MN et al.: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894 (2007).
48. Moore AF, Jablonski KA, McAteer JB et al.: Extension of Type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes 57(9), 2503-2510 (2008).
49. Iles MM: What can genome-wide association studies tell us about the genetics of common disease? PLoS Genet. 4(2), E33 (2008).
50. Elliott P, Peakman TC; UK Biobank: The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int. J. Epidemiol. 37(2), 234-244 (2008).
51. Janssens AC, Gwinn M, Bradley LA et al.: A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am. J. Hum. Genet. 82(3), 593-599 (2008).
52. Chanock SJ, Manolio T, Boehnke M et al.: Replicating genotype-phenotype associations. Nature 447, 655-660 (2007).
53. Ioannidis JP, Boffetta P, Little J et al.: Assessment of cumulative evidence on genetic associations: interim guidelines. Int. J. Epidemiol. 37(1), 120-132 (2008).
54. Allen NC, Bagade S, McQueen MB et al.: Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 40(7), 827-834 (2008).